{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:05:18Z","timestamp":1793822718442,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T00:00:00Z","timestamp":1470182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T00:00:00Z","timestamp":1470182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Multiple Sclerosis Society and Illinois Department of Public Health Multiple Sclerosis Research Fund Grant","award":["63285002D"],"award-info":[{"award-number":["63285002D"]}],"id":[{"id":"https:\/\/ror.org\/03019wv17","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG019070"],"award-info":[{"award-number":["AG019070"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG045775"],"award-info":[{"award-number":["AG045775"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG028383"],"award-info":[{"award-number":["P30-AG028383"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS034939"],"award-info":[{"award-number":["NS034939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD010649"],"award-info":[{"award-number":["S10OD010649"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004888","name":"Illinois Department of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000117"],"award-info":[{"award-number":["UL1TR000117"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR 000430-09"],"award-info":[{"award-number":["UL1 TR 000430-09"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Genome-wide association studies have identified\n                      <jats:italic>BIN1<\/jats:italic>\n                      within the second most significant susceptibility locus in late-onset Alzheimer\u2019s disease (AD).\n                      <jats:italic>BIN1<\/jats:italic>\n                      undergoes complex alternative splicing to generate multiple isoforms with diverse functions in multiple cellular processes including endocytosis and membrane remodeling. An increase in\n                      <jats:italic>BIN1<\/jats:italic>\n                      expression in AD and an interaction between BIN1 and Tau have been reported. However, disparate descriptions of BIN1 expression and localization in the brain previously reported in the literature and the lack of clarity on brain BIN1 isoforms present formidable challenges to our understanding of how genetic variants in\n                      <jats:italic>BIN1<\/jats:italic>\n                      increase the risk for AD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we analyzed BIN1 mRNA and protein levels in human brain samples from individuals with or without AD. In addition, we characterized the BIN1 expression and isoform diversity in human and rodent tissue by immunohistochemistry and immunoblotting using a panel of BIN1 antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we report on BIN1 isoform diversity in the human brain and document alterations in the levels of select BIN1 isoforms in individuals with AD. In addition, we report striking BIN1 localization to white matter tracts in rodent and the human brain, and document that the large majority of BIN1 is expressed in mature oligodendrocytes whereas neuronal BIN1 represents a minor fraction. This predominant non-neuronal BIN1 localization contrasts with the strict neuronal expression and presynaptic localization of the BIN1 paralog, Amphiphysin 1. We also observe upregulation of BIN1 at the onset of postnatal myelination in the brain and during differentiation of cultured oligodendrocytes. Finally, we document that the loss of BIN1 significantly correlates with the extent of demyelination in multiple sclerosis lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our study provides new insights into the brain distribution and cellular expression of an important risk factor associated with late-onset AD. We propose that efforts to define how genetic variants in\n                      <jats:italic>BIN1<\/jats:italic>\n                      elevate the risk for AD would behoove to consider BIN1 function in the context of its main expression in mature oligodendrocytes and the potential for a role of BIN1 in the membrane remodeling that accompanies the process of myelination.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-016-0124-1","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T08:45:13Z","timestamp":1470213913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Predominant expression of Alzheimer\u2019s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts"],"prefix":"10.1186","volume":"11","author":[{"given":"Pierre","family":"De Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Buggia-Pr\u00e9vot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L. L.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared B.","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carson","family":"van Sanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Lesnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bott\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Deyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Someya","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshaan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyabrata","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Popko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pytel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Estus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-6780","authenticated-orcid":false,"given":"Gopal","family":"Thinakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"key":"124_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00109-014-1138-1","volume":"92","author":"I Prokic","year":"2014","unstructured":"Prokic I, Cowling BS, Laporte J. Amphiphysin 2 (BIN1) in physiology and diseases. J Mol Med. 2014;92:453\u201363.","journal-title":"J Mol Med"},{"key":"124_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ng0996-69","volume":"14","author":"D Sakamuro","year":"1996","unstructured":"Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet. 1996;14:69\u201377.","journal-title":"Nat Genet"},{"key":"124_CR3","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/j.1460-2075.1992.tb05317.x","volume":"11","author":"B Lichte","year":"1992","unstructured":"Lichte B, Veh RW, Meyer HE, Kilimann MW. Amphiphysin, a novel protein associated with synaptic vesicles. EMBO J. 1992;11:2521\u201330.","journal-title":"EMBO J"},{"key":"124_CR4","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1083\/jcb.137.6.1355","volume":"137","author":"MH Butler","year":"1997","unstructured":"Butler MH, David C, Ochoa GC, Freyberg Z, Daniell L, Grabs D, Cremona O, De Camilli P. Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin\/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. J Cell Biol. 1997;137:1355\u201367.","journal-title":"J Cell Biol"},{"key":"124_CR5","doi-asserted-by":"publisher","first-page":"16700","DOI":"10.1074\/jbc.272.26.16700","volume":"272","author":"AR Ramjaun","year":"1997","unstructured":"Ramjaun AR, Micheva KD, Bouchelet I, McPherson PS. Identification and characterization of a nerve terminal-enriched amphiphysin isoform. J Biol Chem. 1997;272:16700\u20136.","journal-title":"J Biol Chem"},{"key":"124_CR6","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.1074\/jbc.272.24.15101","volume":"272","author":"C Leprince","year":"1997","unstructured":"Leprince C, Romero F, Cussac D, Vayssiere B, Berger R, Tavitian A, Camonis JH. A new member of the amphiphysin family connecting endocytosis and signal transduction pathways. J Biol Chem. 1997;272:15101\u20135.","journal-title":"J Biol Chem"},{"key":"124_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1006\/bbrc.1997.6927","volume":"236","author":"K Tsutsui","year":"1997","unstructured":"Tsutsui K, Maeda Y, Tsutsui K, Seki S, Tokunaga A. cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants. Biochem Biophys Res Commun. 1997;236:178\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"124_CR8","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1091\/mbc.8.10.2003","volume":"8","author":"P Wigge","year":"1997","unstructured":"Wigge P, Kohler K, Vallis Y, Doyle CA, Owen D, Hunt SP, McMahon HT. Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell. 1997;8:2003\u201315.","journal-title":"Mol Biol Cell"},{"key":"124_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0166-2236(98)01264-8","volume":"21","author":"P Wigge","year":"1998","unstructured":"Wigge P, McMahon HT. The amphiphysin family of proteins and their role in endocytosis at the synapse. Trends Neurosci. 1998;21:339\u201344.","journal-title":"Trends Neurosci"},{"key":"124_CR10","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1128\/MCB.23.12.4295-4306.2003","volume":"23","author":"AJ Muller","year":"2003","unstructured":"Muller AJ, Baker JF, DuHadaway JB, Ge K, Farmer G, Donover PS, et al. Targeted disruption of the murine Bin1\/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation. Mol Cell Biol. 2003;23:4295\u2013306.","journal-title":"Mol Cell Biol"},{"key":"124_CR11","first-page":"25","volume":"1795","author":"GC Prendergast","year":"2009","unstructured":"Prendergast GC, Muller AJ, Ramalingam A, Chang MY. BAR the door: cancer suppression by amphiphysin-like genes. Biochim Biophys Acta. 2009;1795:25\u201336.","journal-title":"Biochim Biophys Acta"},{"key":"124_CR12","doi-asserted-by":"publisher","first-page":"31453","DOI":"10.1074\/jbc.272.50.31453","volume":"272","author":"R Wechsler-Reya","year":"1997","unstructured":"Wechsler-Reya R, Sakamuro D, Zhang J, Duhadaway J, Prendergast GC. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem. 1997;272:31453\u20138.","journal-title":"J Biol Chem"},{"key":"124_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/jcb.10380","volume":"88","author":"JB DuHadaway","year":"2003","unstructured":"DuHadaway JB, Lynch FJ, Brisbay S, Bueso-Ramos C, Troncoso P, McDonnell T, Prendergast GC. Immunohistochemical analysis of Bin1\/Amphiphysin II in human tissues: diverse sites of nuclear expression and losses in prostate cancer. J Cell Biochem. 2003;88:635\u201342.","journal-title":"J Cell Biochem"},{"key":"124_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0014-5793(97)01016-8","volume":"414","author":"KD Micheva","year":"1997","unstructured":"Micheva KD, Ramjaun AR, Kay BK, McPherson PS. SH3 domain-dependent interactions of endophilin with amphiphysin. FEBS Lett. 1997;414:308\u201312.","journal-title":"FEBS Lett"},{"key":"124_CR15","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1093\/emboj\/17.18.5273","volume":"17","author":"DJ Owen","year":"1998","unstructured":"Owen DJ, Wigge P, Vallis Y, Moore JD, Evans PR, McMahon HT. Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation. EMBO J. 1998;17:5273\u201385.","journal-title":"EMBO J"},{"key":"124_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng2086","volume":"39","author":"AS Nicot","year":"2007","unstructured":"Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, Iwarsson E, et al. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet. 2007;39:1134\u20139.","journal-title":"Nat Genet"},{"key":"124_CR17","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.molcel.2012.05.037","volume":"46","author":"JD Ellis","year":"2012","unstructured":"Ellis JD, Barrios-Rodiles M, Colak R, Irimia M, Kim T, Calarco JA, et al. Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol Cell. 2012;46:884\u201392.","journal-title":"Mol Cell"},{"key":"124_CR18","doi-asserted-by":"publisher","first-page":"12390","DOI":"10.1073\/pnas.94.23.12390","volume":"94","author":"L Kadlec","year":"1997","unstructured":"Kadlec L, Pendergast AM. The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation. Proc Natl Acad Sci U S A. 1997;94:12390\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR19","doi-asserted-by":"publisher","first-page":"27674","DOI":"10.1074\/jbc.M109.029538","volume":"284","author":"P Fernando","year":"2009","unstructured":"Fernando P, Sandoz JS, Ding W, de Repentigny Y, Brunette S, Kelly JF, Kothary R, Megeney LA. Bin1 SRC homology 3 domain acts as a scaffold for myofiber sarcomere assembly. J Biol Chem. 2009;284:27674\u201386.","journal-title":"J Biol Chem"},{"key":"124_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.15252\/emmm.201404436","volume":"6","author":"S Falcone","year":"2014","unstructured":"Falcone S, Roman W, Hnia K, Gache V, Didier N, Laine J, et al. N-WASP is required for Amphiphysin-2\/BIN1-dependent nuclear positioning and triad organization in skeletal muscle and is involved in the pathophysiology of centronuclear myopathy. EMBO Mol Med. 2014;6:1455\u201375.","journal-title":"EMBO Mol Med"},{"key":"124_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-015-0237-8","volume":"3","author":"Y Sottejeau","year":"2015","unstructured":"Sottejeau Y, Bretteville A, Cantrelle FX, Malmanche N, Demiaute F, Mendes T, et al. Tau phosphorylation regulates the interaction between BIN1\u2019s SH3 domain and Tau\u2019s proline-rich domain. Acta Neuropathol Commun. 2015;3:58.","journal-title":"Acta Neuropathol Commun"},{"key":"124_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1088\u201393.","journal-title":"Nat Genet"},{"key":"124_CR23","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303:1832\u201340.","journal-title":"JAMA"},{"key":"124_CR24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","volume":"19","author":"MS Tan","year":"2013","unstructured":"Tan MS, Yu JT, Tan L. Bridging integrator 1 (BIN1): form, function, and Alzheimer\u2019s disease. Trends Mol Med. 2013;19:594\u2013603.","journal-title":"Trends Mol Med"},{"key":"124_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17\u201323.","journal-title":"Nat Genet"},{"key":"124_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry. 2013;18:1225\u201334.","journal-title":"Mol Psychiatry"},{"key":"124_CR27","doi-asserted-by":"crossref","unstructured":"Miyagawa T, Ebinuma I, Morohashi Y, Hori Y, Chang MY, Hattori H, et al. BIN1 regulates BACE1 intracellular trafficking and amyloid-beta production. Hum Mol Genet. 2016","DOI":"10.1093\/hmg\/ddw146"},{"key":"124_CR28","doi-asserted-by":"publisher","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS One. 2012;7:e50976.","journal-title":"PLoS One"},{"key":"124_CR29","doi-asserted-by":"publisher","first-page":"e78806","DOI":"10.1371\/journal.pone.0078806","volume":"8","author":"EB Glennon","year":"2013","unstructured":"Glennon EB, Whitehouse IJ, Miners JS, Kehoe PG, Love S, Kellett KA, Hooper NM. BIN1 is decreased in sporadic but not familial Alzheimer\u2019s disease or in aging. PLoS One. 2013;8:e78806.","journal-title":"PLoS One"},{"key":"124_CR30","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-132450","volume":"42","author":"CJ Holler","year":"2014","unstructured":"Holler CJ, Davis PR, Beckett TL, Platt TL, Webb RL, Head E, Murphy MP. Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer\u2019s disease brain and correlates with neurofibrillary tangle pathology. J Alzheimers Dis. 2014;42:1221\u20137.","journal-title":"J Alzheimers Dis"},{"key":"124_CR31","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.neurobiolaging.2014.09.003","volume":"36","author":"H Martiskainen","year":"2015","unstructured":"Martiskainen H, Viswanathan J, Nykanen NP, Kurki M, Helisalmi S, Natunen T, et al. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models. Neurobiol Aging. 2015;36:1221. e1215-1228.","journal-title":"Neurobiol Aging"},{"key":"124_CR32","doi-asserted-by":"publisher","first-page":"10967","DOI":"10.1523\/JNEUROSCI.2572-06.2006","volume":"26","author":"JC Dugas","year":"2006","unstructured":"Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci. 2006;26:10967\u201383.","journal-title":"J Neurosci"},{"key":"124_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/hmg\/ddm365","volume":"17","author":"F Zou","year":"2008","unstructured":"Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, Simpson JF, et al. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer\u2019s disease. Hum Mol Genet. 2008;17:929\u201335.","journal-title":"Hum Mol Genet"},{"key":"124_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1326-4-46","volume":"4","author":"KE Grear","year":"2009","unstructured":"Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, Peterson SL, et al. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Mol Neurodegener. 2009;4:46.","journal-title":"Mol Neurodegener"},{"key":"124_CR35","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/humu.21244","volume":"31","author":"IF Ling","year":"2010","unstructured":"Ling IF, Estus S. Role of SFRS13A in low-density lipoprotein receptor splicing. Hum Mutat. 2010;31:702\u20139.","journal-title":"Hum Mutat"},{"key":"124_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neulet.2008.11.006","volume":"450","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Abner EL, Scheff SW, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Patel E, Markesbery WR. Alzheimer\u2019s-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neurosci Lett. 2009;450:336\u20139.","journal-title":"Neurosci Lett"},{"key":"124_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR. Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol. 2009;68:1\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"124_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/NEN.0b013e3181d8db07","volume":"69","author":"PT Nelson","year":"2010","unstructured":"Nelson PT, Kukull WA, Frosch MP. Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol. 2010;69:449\u201354.","journal-title":"J Neuropathol Exp Neurol"},{"key":"124_CR39","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1038\/ncomms7532","volume":"6","author":"SW Way","year":"2015","unstructured":"Way SW, Podojil JR, Clayton BL, Zaremba A, Collins TL, Kunjamma RB, et al. Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nat Commun. 2015;6:6532.","journal-title":"Nat Commun"},{"key":"124_CR40","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.celrep.2013.12.006","volume":"5","author":"V Buggia-Pr\u00e9vot","year":"2013","unstructured":"Buggia-Pr\u00e9vot V, Fernandez CG, Udayar V, Vetrivel KS, Elie A, Roseman J, et al. A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer\u2019s disease A\u03b2 production. Cell Rep. 2013;5:1552\u201363.","journal-title":"Cell Rep"},{"key":"124_CR41","doi-asserted-by":"publisher","first-page":"e91242","DOI":"10.1371\/journal.pone.0091242","volume":"9","author":"I Parikh","year":"2014","unstructured":"Parikh I, Fardo DW, Estus S. Genetics of PICALM expression and Alzheimer\u2019s disease. PLoS One. 2014;9:e91242.","journal-title":"PLoS One"},{"key":"124_CR42","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","volume":"33","author":"M Malik","year":"2013","unstructured":"Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S. CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci. 2013;33:13320\u20135.","journal-title":"J Neurosci"},{"key":"124_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-1","volume":"9","author":"V Buggia-Prevot","year":"2014","unstructured":"Buggia-Prevot V, Fernandez CG, Riordan S, Vetrivel KS, Roseman J, Waters J, Bindokas VP, Vassar R, Thinakaran G. Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase. Mol Neurodegener. 2014;9:1.","journal-title":"Mol Neurodegener"},{"key":"124_CR44","unstructured":"Rasband WS: ImageJ. Bethesda, Maryland, USA: U. S. National Institutes of Health; 1997\u20132016"},{"key":"124_CR45","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34:11929\u201347.","journal-title":"J Neurosci"},{"key":"124_CR46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet. 2011;43:436\u201341.","journal-title":"Nat Genet"},{"key":"124_CR47","first-page":"3258","volume":"57","author":"R Wechsler-Reya","year":"1997","unstructured":"Wechsler-Reya R, Elliott K, Herlyn M, Prendergast GC. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. Cancer Res. 1997;57:3258\u201363.","journal-title":"Cancer Res"},{"key":"124_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1073\/pnas.93.1.331","volume":"93","author":"C David","year":"1996","unstructured":"David C, McPherson PS, Mundigl O, de Camilli P. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. Proc Natl Acad Sci U S A. 1996;93:331\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR49","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/emboj\/16.5.978","volume":"16","author":"E Peles","year":"1997","unstructured":"Peles E, Nativ M, Lustig M, Grumet M, Schilling J, Martinez R, Plowman GD, Schlessinger J. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J. 1997;16:978\u201388.","journal-title":"EMBO J"},{"key":"124_CR50","doi-asserted-by":"publisher","first-page":"14605","DOI":"10.1073\/pnas.0905936106","volume":"106","author":"A Ishii","year":"2009","unstructured":"Ishii A, Dutta R, Wark GM, Hwang SI, Han DK, Trapp BD, Pfeiffer SE, Bansal R. Human myelin proteome and comparative analysis with mouse myelin. Proc Natl Acad Sci U S A. 2009;106:14605\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR51","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1084\/jem.20101974","volume":"209","author":"MH Han","year":"2012","unstructured":"Han MH, Lundgren DH, Jaiswal S, Chao M, Graham KL, Garris CS, et al. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J Exp Med. 2012;209:1325\u201334.","journal-title":"J Exp Med"},{"key":"124_CR52","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1073\/pnas.012025199","volume":"99","author":"AI Su","year":"2002","unstructured":"Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A. 2002;99:4465\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/ahg.12000","volume":"77","author":"P Holton","year":"2013","unstructured":"Holton P, Ryten M, Nalls M, Trabzuni D, Weale ME, Hernandez D, et al. Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet. 2013;77:85\u2013105.","journal-title":"Ann Hum Genet"},{"key":"124_CR54","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1038\/sj.onc.1203681","volume":"19","author":"K Elliott","year":"2000","unstructured":"Elliott K, Ge K, Du W, Prendergast GC. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene. 2000;19:4669\u201384.","journal-title":"Oncogene"},{"key":"124_CR55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1034\/j.1600-0854.2001.21113.x","volume":"2","author":"PA Leventis","year":"2001","unstructured":"Leventis PA, Chow BM, Stewart BA, Iyengar B, Campos AR, Boulianne GL. Drosophila Amphiphysin is a post-synaptic protein required for normal locomotion but not endocytosis. Traffic. 2001;2:839\u201350.","journal-title":"Traffic"},{"key":"124_CR56","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1101\/gad.207801","volume":"15","author":"A Razzaq","year":"2001","unstructured":"Razzaq A, Robinson IM, McMahon HT, Skepper JN, Su Y, Zelhof AC, Jackson AP, Gay NJ, O\u2019Kane CJ. Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. Genes Dev. 2001;15:2967\u201379.","journal-title":"Genes Dev"},{"key":"124_CR57","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1242\/dev.128.24.5005","volume":"128","author":"AC Zelhof","year":"2001","unstructured":"Zelhof AC, Bao H, Hardy RW, Razzaq A, Zhang B, Doe CQ. Drosophila Amphiphysin is implicated in protein localization and membrane morphogenesis but not in synaptic vesicle endocytosis. Development. 2001;128:5005\u201315.","journal-title":"Development"},{"key":"124_CR58","doi-asserted-by":"crossref","unstructured":"Adams SL, Tilton K, Kozubek JA, Seshadri S, Delalle I. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology. J Neuropathol Exp Neurol. 2016","DOI":"10.1093\/jnen\/nlw056"},{"key":"124_CR59","doi-asserted-by":"publisher","first-page":"15307","DOI":"10.1073\/pnas.1201632109","volume":"109","author":"J Bali","year":"2012","unstructured":"Bali J, Gheinani AH, Zurbriggen S, Rajendran L. Role of genes linked to sporadic Alzheimer\u2019s disease risk in the production of beta-amyloid peptides. Proc Natl Acad Sci U S A. 2012;109:15307\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR60","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1073\/pnas.92.22.10369","volume":"92","author":"P LoPresti","year":"1995","unstructured":"LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI. Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci U S A. 1995;92:10369\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR61","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1523\/JNEUROSCI.22-03-00698.2002","volume":"22","author":"C Klein","year":"2002","unstructured":"Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci. 2002;22:698\u2013707.","journal-title":"J Neurosci"},{"key":"124_CR62","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0197-4580(01)00218-4","volume":"22","author":"R Vlkolinsk\u00fd","year":"2001","unstructured":"Vlkolinsk\u00fd R, Cairns N, Fountoulakis M, Lubec G. Decreased brain levels of 2\u2019,3\u2019-cyclic nucleotide-3\u2019-phosphodiesterase in Down syndrome and Alzheimer\u2019s disease. Neurobiol Aging. 2001;22:547\u201353.","journal-title":"Neurobiol Aging"},{"key":"124_CR63","doi-asserted-by":"publisher","first-page":"11080","DOI":"10.1021\/bi026173d","volume":"41","author":"AE Roher","year":"2002","unstructured":"Roher AE, Weiss N, Kokjohn TA, Kuo Y-M, Kalback W, Anthony J, et al. Increased A\u03b2 peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer\u2019s disease. Biochemistry. 2002;41:11080\u201390.","journal-title":"Biochemistry"},{"key":"124_CR64","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/glia.22295","volume":"60","author":"W Kamphuis","year":"2012","unstructured":"Kamphuis W, Orre M, Kooijman L, Dahmen M, Hol EM. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer\u2019s disease mouse model. Glia. 2012;60:615\u201329.","journal-title":"Glia"},{"key":"124_CR65","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1750-3639.2012.00595.x","volume":"22","author":"E Gagyi","year":"2012","unstructured":"Gagyi E, Kormos B, Castellanos KJ, Valyi-Nagy K, Korneff D, LoPresti P, Woltjer R, Valyi-Nagy T. Decreased oligodendrocyte nuclear diameter in Alzheimer\u2019s disease and Lewy body dementia. Brain pathology (Zurich, Switzerland). 2012;22:803\u201310.","journal-title":"Brain pathology (Zurich, Switzerland)"},{"key":"124_CR66","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/glia.20734","volume":"57","author":"MK Desai","year":"2009","unstructured":"Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ. Triple-transgenic Alzheimer\u2019s disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia. 2009;57:54\u201365.","journal-title":"Glia"},{"key":"124_CR67","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00401-010-0657-2","volume":"119","author":"S Mitew","year":"2010","unstructured":"Mitew S, Kirkcaldie MTK, Halliday GM, Shepherd CE, Vickers JC, Dickson TC. Focal demyelination in Alzheimer\u2019s disease and transgenic mouse models. Acta Neuropathol. 2010;119:567\u201377.","journal-title":"Acta Neuropathol"},{"key":"124_CR68","first-page":"416","volume":"2012","author":"BT Gold","year":"1822","unstructured":"Gold BT, Johnson NF, Powell DK, Smith CD. White matter integrity and vulnerability to Alzheimer\u2019s disease: preliminary findings and future directions. Biochim Biophys Acta. 1822;2012:416\u201322.","journal-title":"Biochim Biophys Acta"},{"key":"124_CR69","doi-asserted-by":"crossref","first-page":"RC118","DOI":"10.1523\/JNEUROSCI.21-01-j0001.2001","volume":"21","author":"J Xu","year":"2001","unstructured":"Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci. 2001;21:RC118.","journal-title":"J Neurosci"},{"key":"124_CR70","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2353\/ajpath.2010.100087","volume":"177","author":"MK Desai","year":"2010","unstructured":"Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, Bowers WJ. Early oligodendrocyte\/myelin pathology in Alzheimer\u2019s disease mice constitutes a novel therapeutic target. Am J Pathol. 2010;177:1422\u201335.","journal-title":"Am J Pathol"},{"key":"124_CR71","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/glia.22432","volume":"61","author":"G Behrendt","year":"2013","unstructured":"Behrendt G, Baer K, Buffo A, Curtis MA, Faull RL, Rees MI, Gotz M, Dimou L. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia. 2013;61:273\u201386.","journal-title":"Glia"}],"updated-by":[{"DOI":"10.1186\/s13024-023-00662-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000}}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-016-0124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-016-0124-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-016-0124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:06:40Z","timestamp":1696230400000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-016-0124-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1186\/s13024-016-0124-1","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]},"assertion":[{"value":"28 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13024-023-00662-z","URL":"https:\/\/doi.org\/10.1186\/s13024-023-00662-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"59"}}